argenx SE | ARGX - Despesas Operacionais





Despesas Operacionais Alterar Data
AstraZeneca USD 8.18B 4.35B 2026-03
Genmab DKK 798M 235M 2025-12
GlaxoSmithKline GBP 5.34B 1.85B 2026-03
GRIFOLS EUR 1.45B 255.28M 2026-03
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Lakefront Biotherapeutics EUR 70.18M 50.08M 2026-03
Qiagen NV USD 375.69M 42.85M 2026-03
UCB EUR 2.96B 196M 2025-12